Pankaj Modi

Summary

Publications

  1. ncbi request reprint The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System
    Pankaj Modi
    VP Research and Development, Generex Biotechnology Corporation, Toronto, Ontario, Canada
    Diabetes Metab Res Rev 18:S38-42. 2002
  2. ncbi request reprint Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus
    Pankaj Modi
    Innovatech Rx, 519 Golf Links Road, Ancaster, Ontario L9G4X6, Canada
    Curr Drug Discov Technol 4:39-47. 2007
  3. ncbi request reprint Metabolic syndrome--risk factors for atherosclerosis and diabetes
    Marko Mihic
    Diabetes Care and Research Clinic, St Joseph Hospital, University of Toronto, Toronto, Canada
    Curr Diabetes Rev 4:122-8. 2008
  4. ncbi request reprint Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management
    Pankaj Modi
    Innovatech Corporation, 519 Golf Links Road, Ancaster, ON, L9G 4X6, Canada
    Curr Drug Discov Technol 6:200-13. 2009
  5. ncbi request reprint Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique
    Simona Cernea
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, PO Box 12000, Jerusalem 91120, Israel
    Clin Ther 26:2084-91. 2004
  6. ncbi request reprint Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study
    Jaime Guevara-Aguirre
    Institute of Endocrinology IEMIR, Quito, Ecuador
    Diabetes Metab Res Rev 20:472-8. 2004
  7. ncbi request reprint Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents
    Jaime Guevara-Aguirre
    Institute of Endocrinology IEMIR, Quito, Ecuador
    Diabetes Technol Ther 6:1-8. 2004
  8. ncbi request reprint Dose-response relationship of oral insulin spray in healthy subjects
    Simona Cernea
    Diabetes Unit, Dept of Medicine, Hadassah Hospital, POB 12000, Jerusalem, Israel 91120
    Diabetes Care 28:1353-7. 2005
  9. doi request reprint Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India
    Abhijit Chandra
    King George Medical University, Lucknow, India
    Surg Infect (Larchmt) 9:367-76. 2008
  10. ncbi request reprint Biokinetics of buccal spray insulin in patients with type 1 diabetes
    Paolo Pozzilli
    Department of Endocrinoplogy and Diabetes, University Campus Bio Medico, Rome, Italy
    Metabolism 54:930-4. 2005

Collaborators

  • Andrew Lewin
  • Paolo Pozzilli
  • Marko Mihic
  • Simona Cernea
  • Jaime Guevara-Aguirre
  • Abhijit Chandra
  • Miriam Kidron
  • Itamar Raz
  • Jay Wohlgelernter
  • Jeannette Saavedra
  • Marco Guevara
  • Sanjay Somasundaram
  • Shashank Shah
  • R A Sastry
  • Chetan Desai
  • Maddibande R Sreevathsa
  • Puja Kochhar
  • Manjula Schou
  • Mayakonda K Ramesh
  • Satish Dharap
  • Puneet Dhar
  • Ashok K Mathur
  • Vinay K Kapoor
  • Otivilvayoth V Sudheer
  • Mahendra Narwaria
  • Hariharan Ramesh
  • Satpalsingh Virk
  • Subodh Varshney
  • Amitabh Goel
  • Jayprakash V Hardikar
  • Rajesh Gupta

Detail Information

Publications10

  1. ncbi request reprint The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System
    Pankaj Modi
    VP Research and Development, Generex Biotechnology Corporation, Toronto, Ontario, Canada
    Diabetes Metab Res Rev 18:S38-42. 2002
    ....
  2. ncbi request reprint Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus
    Pankaj Modi
    Innovatech Rx, 519 Golf Links Road, Ancaster, Ontario L9G4X6, Canada
    Curr Drug Discov Technol 4:39-47. 2007
    ..These agents have distinct characteristics that help in their selection for the treatment of type 1 and type 2 diabetes...
  3. ncbi request reprint Metabolic syndrome--risk factors for atherosclerosis and diabetes
    Marko Mihic
    Diabetes Care and Research Clinic, St Joseph Hospital, University of Toronto, Toronto, Canada
    Curr Diabetes Rev 4:122-8. 2008
    ..To evaluate the lipoprotein profiles, triglycerides and glycemia along with the abdominal fat to explore the risk factors associated with non-diabetic state to IGF, IGT and Type-2 diabetes in Canadian population...
  4. ncbi request reprint Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management
    Pankaj Modi
    Innovatech Corporation, 519 Golf Links Road, Ancaster, ON, L9G 4X6, Canada
    Curr Drug Discov Technol 6:200-13. 2009
    ..This review discusses how these approaches can help patients manage their diabetes effectively by considering new insulin formulations and delivery devices and newer therapeutics...
  5. ncbi request reprint Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique
    Simona Cernea
    Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, PO Box 12000, Jerusalem 91120, Israel
    Clin Ther 26:2084-91. 2004
    ..This system delivers an aerosol of uniform-sized droplets containing regular human insulin at a high velocity into the oropharyngeal cavity for local transmucosal absorption...
  6. ncbi request reprint Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study
    Jaime Guevara-Aguirre
    Institute of Endocrinology IEMIR, Quito, Ecuador
    Diabetes Metab Res Rev 20:472-8. 2004
    ..Proof-of-concept study of evaluation of metabolic effect of novel oral spray insulin (Oralin) formulation at breakfast time in subjects with type 2 diabetes on multiple daily injections...
  7. ncbi request reprint Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents
    Jaime Guevara-Aguirre
    Institute of Endocrinology IEMIR, Quito, Ecuador
    Diabetes Technol Ther 6:1-8. 2004
    ..This study results demonstrated that Oralin could be used as meal insulin as an add-on therapy in combination with failing OHAs treatment in subjects with type 2 diabetes to regulate postprandial glucose levels...
  8. ncbi request reprint Dose-response relationship of oral insulin spray in healthy subjects
    Simona Cernea
    Diabetes Unit, Dept of Medicine, Hadassah Hospital, POB 12000, Jerusalem, Israel 91120
    Diabetes Care 28:1353-7. 2005
    ..To evaluate the pharmacodynamic and pharmacokinetic properties and the dose-ranging effects of an oral insulin spray in comparison with subcutaneous regular insulin...
  9. doi request reprint Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India
    Abhijit Chandra
    King George Medical University, Lucknow, India
    Surg Infect (Larchmt) 9:367-76. 2008
    ..Simpler regimens that preserve an adequate spectrum of coverage, but allow easier administration and have fewer side effects, may be a more desirable option...
  10. ncbi request reprint Biokinetics of buccal spray insulin in patients with type 1 diabetes
    Paolo Pozzilli
    Department of Endocrinoplogy and Diabetes, University Campus Bio Medico, Rome, Italy
    Metabolism 54:930-4. 2005
    ..To evaluate the metabolic effect of buccal spray insulin compared with subcutaneous regular insulin in patients with type 1 diabetes...